According to the  American Journal of Obstetrics and Gynecology, screening for<unk><unk> , done by measuring anti-TPO antibodies is recommended for every pregnant woman. According to the Endocrinology and Metabolism Clinics of North America, screening for<unk><unk>  in first trimester, by measuring anti-TPO antibodies, should be limited to every high-risk pregnant women with type 1 DM and history of<unk><unk> . According to these recommendations, any patient with high risk of PPT should be followed with TSH levels in every 6th and 9th<unk>  month.
Postpartum thyroiditis screening
Multiple endocrine neoplasia type 1 screening
Adrenal atrophy screening
Turner syndrome screening
Growth hormone deficiency screening
Androgen insensitivity syndrome screening
Gestational diabetes screening
Hamartoma screening